Enrolling by invitationPhase 4NCT05019027

N-of-1 for Beta-Blockers in Cardiac Amyloidosis

Studying Wild type ATTR amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Weill Medical College of Cornell University
Principal Investigator
Parag Goyal, MD, MSc
Weill Medical College of Cornell University
Intervention
Beta blocker(drug)
Enrollment
20 enrolled
Eligibility
65 years · All sexes
Timeline
2024 – 2026

Study locations (1)

Collaborators

U.S. Deprescribing Research Network

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05019027 on ClinicalTrials.gov

Other trials for Wild type ATTR amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Wild type ATTR amyloidosis →

← Back to all trials